SEC Form 4 · accession 0000899243-17-008884
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Furnas
Director · Other
Period of report
Mar 27, 2017
Accepted (ET)
Mar 30, 2017 · 11:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.96 | Mar 27, 2017 | A | 75,000 | A | — | Mar 26, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on the first anniversary of the grant date, subject to continued service.
Remarks
1. The Reporting Person may be deemed to be a member of a Section 13 (d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock.